Failure of Decidualization and Maternal Immune Tolerance Underlies Uterovascular Resistance in Intra Uterine Growth Restriction.
EVT
IUGR
T cells
decidua
dendritic
immunology
progesterone
uterovascular transformation
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2019
2019
Historique:
received:
26
10
2018
accepted:
25
02
2019
entrez:
6
4
2019
pubmed:
6
4
2019
medline:
6
4
2019
Statut:
epublish
Résumé
Failure of uterine vascular transformation is associated with pregnancy complications including Intra Uterine Growth Restriction (IUGR). The decidua and its immune cell populations play a key role in the earliest stages of this process. Here we investigate the hypothesis that abnormal decidualization and failure of maternal immune tolerance in the second trimester may underlie the uteroplacental pathology of IUGR. Placental bed biopsies were obtained from women undergoing elective caesarian delivery of a healthy term pregnancy, an IUGR pregnancy or a pregnancy complicated by both IUGR and preeclampsia. Decidual tissues were also collected from second trimester terminations from women with either normal or high uterine artery Doppler pulsatile index (PI). Immunohistochemical image analysis and flow cytometry were used to quantify vascular remodeling, decidual leukocytes and decidual status in cases vs. controls. Biopsies from pregnancies complicated by severe IUGR with a high uterine artery pulsatile index (PI) displayed a lack of: myometrial vascular transformation, interstitial, and endovascular extravillous trophoblast (EVT) invasion, and a lower number of maternal leukocytes. Apoptotic mural EVT were observed in association with mature dendritic cells and T cells in the IUGR samples. Second trimester pregnancies with high uterine artery PI displayed a higher incidence of small for gestational age fetuses; a skewed decidual immunology with higher numbers of; CD8 T cells, mature CD83 dendritic cells and lymphatic vessels that were packed with decidual leukocytes. The decidual stromal cells (DSCs) failed to differentiate into the large secretory DSC in these cases, remaining small and cuboidal and expressing lower levels of the nuclear progesterone receptor isoform B, and DSC markers Insulin Growth Factor Binding protein-1 (IGFBP-1) and CD10 as compared to controls. This study shows that defective progesterone mediated decidualization and a hostile maternal immune response against the invading endovascular EVT contribute to the failure of uterovascular remodeling in IUGR pregnancies.
Identifiants
pubmed: 30949130
doi: 10.3389/fendo.2019.00160
pmc: PMC6436182
doi:
Types de publication
Journal Article
Langues
eng
Pagination
160Références
J Exp Med. 1999 May 3;189(9):1363-72
pubmed: 10224276
Eur J Immunol. 1999 Apr;29(4):1116-26
pubmed: 10229078
J Reprod Immunol. 1999 Nov;45(1):19-30
pubmed: 10660260
Lab Invest. 2001 Aug;81(8):1143-52
pubmed: 11502865
Hum Reprod. 2002 May;17(5):1199-206
pubmed: 11980738
Placenta. 2002 Sep-Oct;23(8-9):555-62
pubmed: 12361674
Am J Obstet Gynecol. 2002 Nov;187(5):1137-42
pubmed: 12439491
Clin Exp Immunol. 2004 May;136(2):373-8
pubmed: 15086404
Placenta. 2004 Sep-Oct;25(8-9):735-41
pubmed: 15450392
J Clin Endocrinol Metab. 2004 Dec;89(12):6155-67
pubmed: 15579772
Mol Immunol. 2005 Feb;42(4):511-21
pubmed: 15607807
BJOG. 2005 Jun;112(6):703-9
pubmed: 15924523
Clin Genet. 2006 Feb;69(2):97-104
pubmed: 16433688
Am J Obstet Gynecol. 2006 Feb;194(2):557-63
pubmed: 16458661
Nat Med. 2006 Sep;12(9):1065-74
pubmed: 16892062
Immunol Rev. 2006 Dec;214:161-85
pubmed: 17100884
Hum Reprod. 2007 Jun;22(6):1705-13
pubmed: 17347164
Fertil Steril. 2007 Jul;88(1):176-87
pubmed: 17383647
Acta Obstet Gynecol Scand. 2007;86(5):530-4
pubmed: 17464579
Am J Reprod Immunol. 2007 Sep;58(3):255-67
pubmed: 17681042
Immunol Lett. 2008 Jan 15;115(1):21-32
pubmed: 18055021
Reprod Sci. 2007 Dec;14(8 Suppl):28-34
pubmed: 18089607
Reprod Biol Endocrinol. 2008 May 06;6:17
pubmed: 18460206
Immunol Invest. 2008;37(5):583-610
pubmed: 18716939
Br J Obstet Gynaecol. 1991 Jul;98(7):648-55
pubmed: 1883787
Am J Pathol. 2009 May;174(5):1959-71
pubmed: 19349361
Reproduction. 2009 Jul;138(1):177-84
pubmed: 19357130
Placenta. 2009 Jun;30(6):473-82
pubmed: 19375795
Am J Obstet Gynecol. 2010 Jun;202(6):561.e1-5
pubmed: 20223448
Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11918-23
pubmed: 20547831
Am J Pathol. 2010 Aug;177(2):1017-30
pubmed: 20558572
Hum Reprod. 2010 Oct;25(10):2455-64
pubmed: 20729537
J Immunol. 2010 Oct 1;185(7):4470-7
pubmed: 20817873
Am J Obstet Gynecol. 2011 Mar;204(3):193-201
pubmed: 21094932
Best Pract Res Clin Obstet Gynaecol. 2011 Jun;25(3):273-85
pubmed: 21212025
PLoS One. 2012;7(1):e30017
pubmed: 22242197
FASEB J. 2012 Jul;26(7):2975-85
pubmed: 22499583
Rev Endocr Metab Disord. 2012 Dec;13(4):265-75
pubmed: 23054374
Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):e93-e101
pubmed: 23288171
Mol Hum Reprod. 2013 Jun;19(6):361-8
pubmed: 23340480
Hypertension. 2013 Dec;62(6):1046-54
pubmed: 24060885
PLoS One. 2014 Feb 20;9(2):e89006
pubmed: 24586479
Acta Obstet Gynecol Scand. 2014 Dec;93(12):1276-81
pubmed: 25155650
Placenta. 2014 Dec;35(12):1027-34
pubmed: 25449030
Placenta. 2015 Apr;36(4):341-4
pubmed: 25637411
J Clin Invest. 2015 Apr;125(4):1726-38
pubmed: 25774501
Mol Endocrinol. 2015 Jun;29(6):882-95
pubmed: 25875046
Am J Obstet Gynecol. 2015 Oct;213(4):488-93
pubmed: 26212182
Histol Histopathol. 2016 May;31(5):557-71
pubmed: 26602431
J Leukoc Biol. 2016 Aug;100(2):315-25
pubmed: 26819320
Am J Pathol. 2016 Apr;186(4):952-61
pubmed: 26851347
Gen Comp Endocrinol. 2017 Feb 1;242:18-23
pubmed: 26965955
Geburtshilfe Frauenheilkd. 2016 Jul;76(7):799-808
pubmed: 27582578
Histochem Cell Biol. 2017 Mar;147(3):353-366
pubmed: 27774579
PLoS One. 2017 Jan 12;12(1):e0169849
pubmed: 28081266
Hum Reprod. 2017 Jun 1;32(6):1208-1217
pubmed: 28369440
Fertil Steril. 2017 Jun;107(6):1269-1272
pubmed: 28577615
Fertil Steril. 2017 Jul;108(1):19-27
pubmed: 28602477
PLoS Pathog. 2017 Nov 2;13(11):e1006624
pubmed: 29095912
Placenta. 2018 Sep;69:125-133
pubmed: 29748088
Am J Reprod Immunol. 2018 Jul;80(1):e12970
pubmed: 29756666
J Am Heart Assoc. 2018 Jul 14;7(14):null
pubmed: 30007936
Am J Reprod Immunol. 2019 Jan;81(1):e13054
pubmed: 30267451
J Clin Invest. 2018 Oct 1;128(10):4224-4235
pubmed: 30272581
J Immunol. 2018 Nov 1;201(9):2551-2556
pubmed: 30275046
Front Immunol. 2018 Nov 13;9:2597
pubmed: 30483261
Br J Obstet Gynaecol. 1986 Oct;93(10):1049-59
pubmed: 3790464
Placenta. 1983;4 Spec No:489-98
pubmed: 6369298
Immunology. 1984 Jun;52(2):349-57
pubmed: 6376338
Placenta. 1983 Oct-Dec;4(4):397-413
pubmed: 6634666
Br J Obstet Gynaecol. 1981 Sep;88(9):876-81
pubmed: 7272259
Placenta. 1980 Jan-Mar;1(1):3-19
pubmed: 7443635
Mol Cell Endocrinol. 1993 Sep;95(1-2):23-9
pubmed: 7694877
Fetal Diagn Ther. 1994 Nov-Dec;9(6):371-8
pubmed: 7880433
Br J Obstet Gynaecol. 1994 Aug;101(8):669-74
pubmed: 7947500
Am J Reprod Immunol. 1997 Oct;38(4):295-301
pubmed: 9352018
Placenta. 1998 May;19(4):241-52
pubmed: 9639319